| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.33B | +18.8% |
| R&D Expense | $90.0M | +5.9% |
| Operating Income | $412.0M | +255.2% |
| Pre-tax Income | $138.0M | +140.2% |
| Income Tax | $87.0M | +1.2% |
| Net Income | $26.0M | +105.8% |
| EPS (Basic) | $0.37 | +105.8% |
| EPS (Diluted) | $0.36 | +105.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $910.0M | -4.3% |
| Accounts Receivable | $989.0M | +19.9% |
| Inventory | $689.0M | +2.8% |
| Current Assets | $3.04B | +4.5% |
| Total Assets | $4.72B | -1.1% |
| Current Liabilities | $1.47B | +10.4% |
| Long-term Debt | $2.20B | -7.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $349.0M | +8.4% |
| Capital Expenditures | $132.0M | +55.3% |
| Investing Cash Flow | -$54.0M | +34.9% |
| Financing Cash Flow | -$248.0M | +38.5% |
| Free Cash Flow | $217.0M | -8.4% |
| Total Liabilities |
| $4.17B |
| -2.5% |
| Stockholders' Equity | $535.0M | +13.3% |